Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected

1. Front Matter

   Pages I-XIII

   PDF

2. Blood Supply Systems and Organisation

   1. Front Matter

      Pages 1-1

      PDF

   2. Blood Transfusion: Quo Vadis? Customer Orientation as the Leading Principal for Blood Banks in the Future

      • Th. E. P. Lotgerink, J. C. Hoekstra

      Pages 3-19

   3. Community Involvement: The Development — the Past, the Present and the Future of Blood Donation as a Form of Community Involvement

      • A. P. M. Los, C. Th. Smit Sibinga

      Pages 21-29

   4. Structure and Commitments Blood Supply Systems and Organization

      • J. C. Emmanuel

      Pages 31-36

   5. Applying Decision Analysis to Transfusion Medicine in the Real World to Improve Transfusion Safety

      • J. P. AuBuchon

      Pages 37-44

   6. Cost-Effectiveness of HIV NAT Screening for Dutch Donors

      • M. J. Postma, A. P. M. Los, E. J. Ruitenberg, C. Th. Smit Sibinga

      Pages 45-51

   7. Legal and Regulatory Aspects of Blood Transfusion

      • M. L. Kavanagh

      Pages 53-66

3. Technical and Pharmaceutical Developments

   1. Front Matter

      Pages 67-67

      PDF

   2. Freezing and Vitrification of Red Cells, Recollections and Predictions

      • H. T. Meryman

      Pages 69-85

   3. Plasma Fractionation

      • P. R. Foster

      Pages 87-101

   4. Viral Marker Screening: Is More Testing Safer?

      • J-P. Allain

      Pages 103-112

   5. Inactivation of Viruses, Bacteria, Protozoa, and Leukocytes in Labile Blood Components by Using Nucleic Acid Targeted Methods

      • L. M. Corash

      Pages 113-123

   6. Alternatives to Human Blood Resources

      • P. M. Ness

      Pages 125-143

4. Quality Principles and Risk Management

   1. Front Matter

      Pages 145-145

      PDF

   2. Quality Systems and Management: 2000 Where Have We Been and Where Are We Going?

      • K. Sazama

      Pages 147-159

   3. Traceability and Coding Principles

      • J. Koistinen

      Pages 161-171

   4. Quality Principles and Risk Management: Automation and Documentation

      • M. Bruce

      Pages 173-187

   5. Haemovigilance

      • N. Drouet

      Pages 189-199

   6. Human Resources: Teaching and Training in Transfusion Medicine

      • J. F. Harrison

      Pages 201-215

th It is a great pleasure for me to open the jubilee 25 International Symposium on Blood Transfusion here in Groningen. This symposium is co-sponsored by the World Health Organization and is being held under the auspices of the ISBT and the Secretary General of the Council of Europe, Mr Walter Schwimmer. The patronage was granted with great pleasure for several reasons. First of all, Dutch experts are very active in our Committees and have largely contributed in developing the Council of Europe principles in the blood area. Secondly, the Council of Europe is active today in the area of blood transfusion due to a tragic event, which occurred in 1953 in the Netherlands; following a flooding many of the blood products given for assistance' could not be used due to incompatibilities and differences in labelling. Some words to present the Council of Europe since the organisation is sometimes confused with institutions ofthe European Union: The organisation has been founded in 1949 to establish the principles of democracy and rule of law all over Europe. Since 1989, the year of the fall of the Berlin wall and the opening up of the iron curtain, these principles could be extended to the countries of Central and Eastern Europe. Today this makes the Council of Europe the only pan-European organisation with 41 Member States thus representing more than 750 million people.

• HIV
• bacteria
• blood
• epidemiology
• gene therapy
• plasma
• transfusion medicine

• Blood Bank Noord Nederland, Groningen, The Netherlands

  C. Th. Smit Sibinga

• Edinburgh, Scotland, UK

  J. D. Cash

Policies and ethics